Concepedia
Statistics
Publications
86
Citations
23.3K
Authors
13
Location
San Diego, United States
Ignyta (United States) is a company institution in San Diego, United States known for medicine, oncology, and pathology.
Top concepts
MedicinePathologyOncologyRadiation OncologyTumor BiologyCancer GeneticsCancer TherapyCell BiologyMolecular OncologyCancer Research
Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1–2 trials
Robert C. Doebele, Alexander Drilon, Luis Paz‐Ares et al. · The Lancet Oncology · 2019 · 1.7K citations · Full text
Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1–2 trials
Alexander Drilon, Salvatore Siena, Rafał Dziadziuszko et al. · The Lancet Oncology · 2019 · 516 citations · Full text
ALK, ROS1, and NTRK Rearrangements in Metastatic Colorectal Cancer
Filippo Pietrantonio, Federica Di Nicolantonio, Alexa B. Schrock et al. · JNCI Journal of the National Cancer Institute · 2017 · 322 citations · Full text
What hides behind the MASC: clinical response and acquired resistance to entrectinib after ETV6-NTRK3 identification in a mammary analogue secretory carcinoma (MASC)
Alexander Drilon, G. Li, Snjezana Doğan et al. · Annals of Oncology · 2016 · 299 citations · Full text
Sensitivity to Entrectinib Associated With a Novel LMNA-NTRK1 Gene Fusion in Metastatic Colorectal Cancer
Andrea Sartore‐Bianchi, Elena Ardini, Roberta Bosotti et al. · JNCI Journal of the National Cancer Institute · 2015 · 245 citations · Full text
Radiation Oncology, Systems Biology, Oncology +15
Rows per page
1–5 of 86
Ignyta (United States), United States
97 publications · 3.8K citations
27
h-index
159 publications · 5.9K citations
25
55 publications · 3.9K citations
18
35 publications · 1.7K citations
33 publications · 2K citations
12
1–5 of 13